| Accession | HRS899454 |
|---|---|
| BioSample Accession | SAMC2930829 |
| Individual accession | HRI684580 |
| Study accession | HRA005098 |
| Sample name | P5_3_BLDC |
| Sample title | P5_3_BLDC |
| Collection date | 2021-05-27 |
| Sample Type | Disease |
| Description | Tislelizumab plus cetuximab and irinotecan in patients with previously treated MSS and RAS wild-type advanced colorectal cancer |
| Tissue | blood cell |
| Release date | 2024-06-01 |